| T3011 / ImmVira Pharma |
NCT05756556: T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma |
|
|
| Suspended | 2 | 68 | US | T3011 + Cobimetinib | ImmVira Pharma Co. Ltd | Melanoma, Malignant Melanoma | 12/26 | 01/27 | | |
NCT05602792: A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1/2 | 233 | RoW | T3011 | ImmVira Pharma Co. Ltd | Advanced Solid Tumor, Sarcoma, HNSCC, Breast Cancer, Esophagus Cancer, NSCLC, Non-melanoma Skin Cancer | 07/23 | 01/24 | | |
NCT04370587: A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors |
|
|
| Recruiting | 1/2 | 64 | US, RoW | T3011, T3011 + pembrolizumab | ImmVira Pharma Co. Ltd | Solid Tumor, Melanoma, HNSCC, Sarcoma, Squamous Cell Carcinoma, NSCLC | 10/23 | 10/25 | | |
NCT06214143: A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors |
|
|
| Recruiting | 1/2 | 68 | RoW | T3011 high dose, T3011 middle dose, T3011 low dose | Shanghai Pharmaceuticals Holding Co., Ltd | Advanced Solid Tumors | 12/25 | 05/26 | | |
NCT06214156: A Clinical Study of T3011 in Subjects With Advanced Melanoma |
|
|
| Recruiting | 1/2 | 42 | RoW | T3011 | Shanghai Pharmaceuticals Holding Co., Ltd | Advanced Melanoma | 09/24 | 07/25 | | |
NCT05598268: A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. |
|
|
| Recruiting | 1/2 | 74 | RoW | T3011 | ImmVira Pharma Co. Ltd | Advanced Solid Tumor, Lung Cancer, Liver Cancer, Lymphoma, Mesothelioma of Pleura | 06/24 | 12/24 | | |
NCT04780217: Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors |
|
|
| Active, not recruiting | 1/2 | 42 | US | T3011 | ImmVira Pharma Co. Ltd | Solid Tumor, Hepatocellular Carcinoma, Colorectal Cancer, NSCLC, Ovarian Cancer, Endometrial Cancer | 03/25 | 08/25 | | |
